The effects of hysterectomy with bilateral salpingectomy on ovarian reserve

To determine whether ovarian reserve is compromised after hysterectomy with bilateral salpingectomy.

[1]  Z. Asgari,et al.  Comparing surgical outcome and ovarian reserve after laparoscopic hysterectomy between two methods of with and without prophylactic bilateral salpingectomy: A randomized controlled trial , 2018, Journal of cancer research and therapeutics.

[2]  Sung-Ho Park,et al.  Assessment of ovarian reserve after hysterectomy: Laparoscopic vs. non-laparoscopic surgery. , 2017, European journal of obstetrics, gynecology, and reproductive biology.

[3]  T. Song,et al.  Impact of opportunistic salpingectomy on anti‐Müllerian hormone in patients undergoing laparoscopic hysterectomy: a multicentre randomised controlled trial , 2017, BJOG : an international journal of obstetrics and gynaecology.

[4]  W. Yeung,et al.  Comparative evaluation of three new commercial immunoassays for anti-Müllerian hormone measurement. , 2016, Human reproduction.

[5]  S. Mukhopadhyay,et al.  DETERIORARON OF OVARIAN FUNCTION AFTER TOTAL ABDOMINAL HYSTERECTOMY WITH PRESERVARON OF OVARIES. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[6]  A. Weaver,et al.  Association of Ovary-Sparing Hysterectomy With Ovarian Reserve , 2016, Obstetrics and gynecology.

[7]  D. Fenner,et al.  Removal of normal ovaries in women under age 51 at the time of hysterectomy. , 2015, American journal of obstetrics and gynecology.

[8]  Yifeng Wang,et al.  Comparing the effect of laparoscopic supracervical and total hysterectomy for uterine fibroids on ovarian reserve by assessing serum anti-mullerian hormone levels: a prospective cohort study. , 2015, Journal of minimally invasive gynecology.

[9]  Richard A. Anderson,et al.  The physiology and clinical utility of anti-Mullerian hormone in women. , 2014, Human reproduction update.

[10]  A. Neugut,et al.  Nationwide Trends in the Performance of Inpatient Hysterectomy in the United States , 2013, Obstetrics and gynecology.

[11]  E. Papaleo,et al.  Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history. , 2012, European journal of obstetrics, gynecology, and reproductive biology.

[12]  C. Atabekoğlu,et al.  The effect of total abdominal hysterectomy on serum anti-Müllerian hormone levels: a pilot study , 2012, Climacteric : the journal of the International Menopause Society.

[13]  S Muttukrishna,et al.  The normal menstrual cycle in women. , 2011, Animal reproduction science.

[14]  Byoung-Gie Kim,et al.  Change in the ovarian environment after hysterectomy as assessed by ovarian arterial blood flow indices and serum anti-Müllerian hormone levels. , 2010, European journal of obstetrics, gynecology, and reproductive biology.

[15]  F. Broekmans,et al.  Ovarian aging: mechanisms and clinical consequences. , 2009, Endocrine reviews.

[16]  Hui Lin,et al.  Body size affects measures of ovarian reserve in late reproductive age women , 2008, Menopause.

[17]  J. Reekers,et al.  Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. , 2007, Human reproduction.

[18]  Karen Farchaus Stein,et al.  Transition! , 2006 .

[19]  Hui Lin,et al.  The relationship between obesity and race on inhibin B during the menopause transition , 2005, Menopause.

[20]  M. Broder,et al.  Ovarian Conservation at the Time of Hysterectomy for Benign Disease , 2007, Clinical obstetrics and gynecology.

[21]  C. Farquhar,et al.  The association of hysterectomy and menopause: a prospective cohort study , 2005, BJOG : an international journal of obstetrics and gynaecology.

[22]  J. Habbema,et al.  Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. , 2005, Fertility and sterility.

[23]  F. Broekmans,et al.  Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition , 2004, Menopause.

[24]  B. Fauser,et al.  Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. , 2004, Molecular human reproduction.

[25]  P. Pearson,et al.  The variability of female reproductive ageing. , 2002, Human reproduction update.

[26]  D. Usher,et al.  Hysterectomy and ovarian function: levels of follicle stimulating hormone and incidence of menopausal symptoms are not affected by hysterectomy in women under age 45 years , 2002, Climacteric : the journal of the International Menopause Society.

[27]  N. Skakkebaek,et al.  Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. , 1999, The Journal of clinical endocrinology and metabolism.

[28]  C. Chalmers.  Does hysterectomy in a premenopausal woman affect ovarian function? , 1996, Medical hypotheses.

[29]  M. Metcalf,et al.  Retention of normal ovarian function after hysterectomy. , 1992, The Journal of endocrinology.

[30]  T. Vuorento,et al.  Follow‐up of ovarian endocrine function in premenopausal women after hysterectomy by daily measurements of salivary progesterone , 1992, Clinical endocrinology.

[31]  P. Donahoe,et al.  Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cells , 1986, Cell.

[32]  A. Treloar,et al.  Menstrual cyclicity and the pre-menopause. , 1981, Maturitas.

[33]  P. Janson,et al.  The acute effect of hysterectomy on ovarian blood flow. , 1977, American journal of obstetrics and gynecology.

[34]  N. Knowlton,et al.  Correlation of ovarian reserve tests with histologically determined primordial follicle number. , 2011, Fertility and sterility.

[35]  M. Eijkemans,et al.  Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. , 2010, Human reproduction.

[36]  A. Durlinger,et al.  Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. , 2002, Endocrinology.